Plain-English translation of NCT07287943 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Medtronic 780G automated insulin delivery system — a smart insulin pump that automatically adjusts insulin doses throughout the day based on your blood sugar readings. The study is designed specifically for adults with type 1 diabetes who also have gastroparesis, a stomach condition that makes it harder to digest food. Researchers want to see if this medication can help people with both conditions manage their blood sugar better and safer than traditional insulin delivery methods.
People with type 1 diabetes who also have gastroparesis face special challenges because their unpredictable stomach function makes blood sugar management much harder. This trial exists to find out whether an automated insulin pump can adapt quickly enough to these challenges and provide better control than older insulin delivery methods.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will either receive the Medtronic 780G automated insulin pump system to use for the duration of the trial, or continue with your current insulin delivery method (injections or a manual pump) as a comparison group. The study involves regular visits to monitor how well the treatment works, check your blood sugar control, and track any side effects. Researchers will measure whether the automated pump helps improve your blood sugar management compared to standard insulin delivery methods.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States